3
Views
1
CrossRef citations to date
0
Altmetric
 

Additional information

Notes on contributors

Margo Michaels

All authors are affiliated with the National Cancer Institute, National Institutes of Health, in Bethesda, Md. Margo Michaels, M.P.H., is an education program specialist in the Public and Survivor Education Section, Office of Education and Special Initiatives. Andrea M. Denicoff R.N., M.S., C.A.N.P., is a clinical trials specialist in the Office of Education and Special Initiatives. Mary Anne Bright R.N., M.N., is the acting chief of the Cancer Information Service. Jeffrey Abrams, M.D., is a senior investigator in the Cancer Therapy Evaluation Program. Detra K. Robinson, M.A., is a project manager with Westat, Inc., in Rockville, Md.

Andrea M. Denicoff

All authors are affiliated with the National Cancer Institute, National Institutes of Health, in Bethesda, Md. Margo Michaels, M.P.H., is an education program specialist in the Public and Survivor Education Section, Office of Education and Special Initiatives. Andrea M. Denicoff R.N., M.S., C.A.N.P., is a clinical trials specialist in the Office of Education and Special Initiatives. Mary Anne Bright R.N., M.N., is the acting chief of the Cancer Information Service. Jeffrey Abrams, M.D., is a senior investigator in the Cancer Therapy Evaluation Program. Detra K. Robinson, M.A., is a project manager with Westat, Inc., in Rockville, Md.

Mary Anne Bright

All authors are affiliated with the National Cancer Institute, National Institutes of Health, in Bethesda, Md. Margo Michaels, M.P.H., is an education program specialist in the Public and Survivor Education Section, Office of Education and Special Initiatives. Andrea M. Denicoff R.N., M.S., C.A.N.P., is a clinical trials specialist in the Office of Education and Special Initiatives. Mary Anne Bright R.N., M.N., is the acting chief of the Cancer Information Service. Jeffrey Abrams, M.D., is a senior investigator in the Cancer Therapy Evaluation Program. Detra K. Robinson, M.A., is a project manager with Westat, Inc., in Rockville, Md.

Jeffrey Abrams

All authors are affiliated with the National Cancer Institute, National Institutes of Health, in Bethesda, Md. Margo Michaels, M.P.H., is an education program specialist in the Public and Survivor Education Section, Office of Education and Special Initiatives. Andrea M. Denicoff R.N., M.S., C.A.N.P., is a clinical trials specialist in the Office of Education and Special Initiatives. Mary Anne Bright R.N., M.N., is the acting chief of the Cancer Information Service. Jeffrey Abrams, M.D., is a senior investigator in the Cancer Therapy Evaluation Program. Detra K. Robinson, M.A., is a project manager with Westat, Inc., in Rockville, Md.

Detra K. Robinson

All authors are affiliated with the National Cancer Institute, National Institutes of Health, in Bethesda, Md. Margo Michaels, M.P.H., is an education program specialist in the Public and Survivor Education Section, Office of Education and Special Initiatives. Andrea M. Denicoff R.N., M.S., C.A.N.P., is a clinical trials specialist in the Office of Education and Special Initiatives. Mary Anne Bright R.N., M.N., is the acting chief of the Cancer Information Service. Jeffrey Abrams, M.D., is a senior investigator in the Cancer Therapy Evaluation Program. Detra K. Robinson, M.A., is a project manager with Westat, Inc., in Rockville, Md.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.